Suppr超能文献

急性呼吸窘迫综合征对肝硬化重症患者预后的影响。

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis.

作者信息

Tariparast Pischtaz Adel, Roedl Kevin, Horvatits Thomas, Drolz Andreas, Kluge Stefan, Fuhrmann Valentin

机构信息

Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

Department of Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Sci Rep. 2025 Feb 4;15(1):4301. doi: 10.1038/s41598-025-88606-z.

Abstract

We investigated the occurrence and outcome of respiratory failure and ARDS in critically ill patients with liver cirrhosis. This is a retrospective analysis of patients with liver cirrhosis at an ICU during an 8-Year period. An assessment of acute on chronic liver failure as well as the presence and grade of ARDS within the first 72 h of admission to the ICU was performed. A total of 735 patients during the study period. Median age was 58 (50-69) years and 61% (n = 447) were male. 57% (n = 421) of the patients received mechanical ventilation (MV). Liver specific as well as ICU scores on admission were significantly higher in patients with MV. Necessity of vasopressor support (86%vs.25%, p < 0.001) and RRT (50%vs.11%, p < 0.001) was more frequent in patients with MV. The incidence of ARDS within the first 72 h of admission was 8% (n = 61). We observed a 28-day mortality or liver transplantation rate of 54% (n = 196) and 66% (n = 66%) in patients with MV and ARDS, respectively. After 90-days 63% (n = 226) with MV and 70% (n = 43) with ARDS were dead or received liver transplantation. ARDS is a prognostic factor for mortality in patients with liver cirrhosis admitted to the ICU. One out of ten critically ill cirrhotic patients develop ARDS within 72 h after admission. Although mortality rates are high initially critical care therapy should not be withheld and must be reevaluated regularly.

摘要

我们调查了肝硬化重症患者呼吸衰竭和急性呼吸窘迫综合征(ARDS)的发生情况及转归。这是一项对某重症监护病房(ICU)8年间肝硬化患者的回顾性分析。对慢性肝衰竭急性发作以及入住ICU后72小时内ARDS的存在情况及分级进行了评估。研究期间共有735例患者。中位年龄为58(50 - 69)岁,61%(n = 447)为男性。57%(n = 421)的患者接受了机械通气(MV)。接受MV的患者入院时肝脏特异性指标以及ICU评分显著更高。MV患者使用血管活性药物支持的必要性(86%对25%,p < 0.001)和肾脏替代治疗(RRT)的必要性(50%对11%,p < 0.001)更为常见。入院后72小时内ARDS的发生率为8%(n = 61)。我们观察到接受MV和ARDS患者的28天死亡率或肝移植率分别为54%(n = 196)和66%(n = 66%)。90天后,接受MV的患者中有63%(n = 226)以及患有ARDS的患者中有70%(n = 43)死亡或接受了肝移植。ARDS是入住ICU的肝硬化患者死亡率的一个预后因素。十分之一的肝硬化重症患者在入院后72小时内发生ARDS。尽管初始死亡率很高,但不应停止重症监护治疗,且必须定期重新评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ea9/11794433/886ac165a279/41598_2025_88606_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验